Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMIEndo: Immunity and Microbiota in Endometriosis
NCT07078435Not yet recruiting
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Identification of immune biomarkers associated with endometriosis at Day 0. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07078435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07078435.